| Gladiator Resources Limited (GLA) ORDINARY FULLY PAID |
Materials |
- |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 10:29AM |
$0.007 |
$0.013 |
risen by
85.71%
|
|
GLA - Price-sensitive ASX Announcement
Full Release
Key Points
- Gladiator Resources Limited (GLA) provided its Quarterly Activities and Appendix 5B Cash Flow Report for the quarter ending 31 December 2023.
- Significant exploration activities occurred in Tanzania, focusing on uranium assets including the flagship Mkuju Project and other prospects.
- At the Mkuju Project, the company completed extensive soil sampling and mapping, identifying multiple uranium mineralisation zones and planning follow-up drilling programs.
- Initial drilling and exploration at the Minjingu Project delineated uranium mineralisation, with further geochemical and geophysical surveys planned.
- Work at other Tanzanian tenements included reconnaissance, sampling, and initial geological mapping to identify further targets.
- In Australia, the company continued monitoring activities at its Bendoc Gold Project, with minimal field activity during the quarter.
- GLA reported a total cash outflow of $976,000 for the quarter, with $621,000 spent on exploration and evaluation activities.
- The company held $2.27 million in cash at the end of the quarter, maintaining a strong financial position to support ongoing exploration.
- No mining production or significant revenue was reported during the quarter.
- The company remains focused on advancing Tanzanian uranium assets, with planned drilling and additional exploration activities scheduled for the upcoming quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mont Royal Resources Limited (MRZ) ORDINARY FULLY PAID |
Materials |
$26 |
Update - Proposed issue of securities - MRZ
|
30 Jul 2025 10:29AM |
$0.041 |
$0.140 |
risen by
241.46%
|
|
| Mont Royal Resources Limited (MRZ) ORDINARY FULLY PAID |
Materials |
$26 |
Commerce Transaction Update
|
30 Jul 2025 10:29AM |
$0.041 |
$0.140 |
risen by
241.46%
|
|
| Zinc of Ireland NL (ZMI) ORDINARY FULLY PAID |
Materials |
$19 |
Change of Director's Interest Notice - PH
|
30 Jul 2025 10:28AM |
$0.008 |
$0.015 |
risen by
87.50%
|
|
| Uvre Limited (UVA) ORDINARY FULLY PAID |
Materials |
$34 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 10:26AM |
$0.135 |
$0.180 |
risen by
33.33%
|
|
UVA - Price-sensitive ASX Announcement
Full Release
Key Points
- East Canyon Uranium-Vanadium Project exploration activities progressed, with site permitting and regulatory steps advanced
- Technical and environmental assessments conducted for East Canyon Project
- Project generation continues, with evaluation of new critical minerals opportunities
- Cash flow report shows operating, investing, and financing cash movements for the quarter
- Closing cash balance and expenditure forecast provided
- Ongoing compliance with ASX listing rules and corporate governance
- Stakeholder and investor engagement activities undertaken
- Focus remains on expanding portfolio in critical minerals to align with market demand
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Zinc of Ireland NL (ZMI) ORDINARY FULLY PAID |
Materials |
$19 |
Change of Director's Interest Notice - JM
|
30 Jul 2025 10:26AM |
$0.008 |
$0.015 |
risen by
87.50%
|
|
| Zinc of Ireland NL (ZMI) ORDINARY FULLY PAID |
Materials |
$19 |
Change of Director's Interest Notice - JB
|
30 Jul 2025 10:24AM |
$0.008 |
$0.015 |
risen by
87.50%
|
|
| Zinc of Ireland NL (ZMI) ORDINARY FULLY PAID |
Materials |
$19 |
Change of Director's Interest Notice - TC
|
30 Jul 2025 10:23AM |
$0.008 |
$0.015 |
risen by
87.50%
|
|
| Weebit Nano Ltd (WBT) ORDINARY FULLY PAID |
Information Technology |
$1,944 |
Application for quotation of securities - WBT
|
30 Jul 2025 10:20AM |
$2.090 |
$8.100 |
risen by
287.56%
|
|
| Altech Batteries Limited (ATC) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 10:20AM |
$0.033 |
$0.008 |
fallen by
75.76%
|
|
ATC - Price-sensitive ASX Announcement
Full Release
Key Points
- Altech Batteries is progressing with its CERENERGY® and Silumina AnodesTM battery projects.
- There is growing industry interest in sodium chloride solid state battery technology.
- Altech has entered into multiple non-binding agreements for battery off-take and is in discussions with various stakeholders.
- The company is collaborating with Fraunhofer IKTS and has achieved significant technical milestones in battery development.
- Financial activities during the quarter included investments in research, development, and capital expenditures.
- Altech maintains a healthy cash balance and is focused on securing additional funding and partnerships.
- Quarterly cash flow report (Appendix 5B) outlines receipts, expenditures, and future funding plans.
- The company continues to advance European battery project initiatives and expand its presence in the battery technology sector.
- No significant negative impacts or material changes to operations were reported for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$215 |
Quarterly Cashflow Report
|
30 Jul 2025 10:18AM |
$0.010 |
$0.024 |
risen by
140%
|
|
ORN - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Cashflow Report covers the period ending 31 March 2023.
- Orion advanced the Prieska Copper-Zinc Project with updated funding agreements with South African institutional lenders.
- Progress was made on the Okiep Copper Project, including partnerships with mining specialists for further development.
- Exploration and permitting activities continued at both primary project sites.
- Environmental, social, and governance (ESG) initiatives were ongoing, supporting local communities and compliance requirements.
- The company reported its cash flows, expenditures, and available funds at the end of the quarter.
- Orion remains committed to advancing its key projects towards production and securing required funding while maintaining financial discipline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$215 |
Quarterly Activities Report
|
30 Jul 2025 10:17AM |
$0.010 |
$0.024 |
risen by
140%
|
|
ORN - Price-sensitive ASX Announcement
Full Release
Key Points
- Advanced feasibility study update for Prieska Copper-Zinc Project.
- Continued engagement with financiers and offtake partners for project funding.
- Progress in regulatory compliance, permitting, and safety initiatives.
- Drilling and exploration activities reported at Okiep Copper Project and other prospects.
- Positive exploration results and further resource definition efforts undertaken.
- Health, safety, and environmental performance reviewed with no major incidents reported.
- Ongoing community engagement and local stakeholder initiatives.
- Summary of quarterly financials with cash balance and operating expenditures outlined.
- Outlook focused on achieving project development milestones and transition to production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NeuroScientific Biopharmaceuticals Ltd (NSB) ORDINARY FULLY PAID |
Health Care |
$23 |
Change in substantial holding
|
30 Jul 2025 10:16AM |
$0.240 |
$0.060 |
fallen by
75%
|
|
| Infinity Mining Limited (IMI) ORDINARY FULLY PAID |
Materials |
$3 |
Form 604 - J Peterson
|
30 Jul 2025 10:14AM |
$0.009 |
$0.006 |
fallen by
33.33%
|
|
| Alterity Therapeutics Limited (ATH) ORDINARY FULLY PAID |
Health Care |
$124 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2025 10:13AM |
$0.014 |
$0.570 |
risen by
3,971.43%
|
|
ATH - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report and Appendix 4C Cash Flow for quarter ended 31 March 2024.
- Ongoing Phase 2 clinical studies of ATH434 for Multiple System Atrophy in Australia/Europe and US.
- Patient dosing and recruitment continue to progress in both clinical studies.
- Preclinical data on ATH434 for Parkinsonian disorders presented at an international conference.
- Cash balance of $14.2 million as of 31 March 2024.
- Net operating cash outflows of $4.5 million during the quarter, primarily for R&D.
- Company projects sufficient cash runway into the second half of 2025.
- Alterity remains focused on advancing its clinical development of ATH434.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Austral Gold Limited (AGD) ORDINARY FULLY PAID |
Materials |
$75 |
Austral Gold Files Q2 2025 Quarterly Activity Report
|
30 Jul 2025 10:10AM |
$0.060 |
$0.113 |
risen by
87.50%
|
|
AGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Q2 2025 report outlines gold and silver production levels at AGD's core assets.
- Exploration activities continued at Guanaco-Amancaya, Casposo, and other properties.
- Cost-reduction strategies and operational efficiencies were implemented amid fluctuating metal prices.
- Corporate updates include regulatory compliance, joint venture progress, and strategic partnerships.
- Financial highlights cover revenue, cash flow, and capital expenditures for the quarter.
- Outlook provided for production, exploration, and financial performance for the remainder of FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magnis Energy Technologies Ltd (MNS) ORDINARY FULLY PAID |
Materials |
$50 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 10:08AM |
$0.042 |
$0.042 |
fallen by
0%
|
|
| Trek Metals Limited (TKM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$98 |
Update on proposed divestment of Hendeka Mn project
|
30 Jul 2025 10:08AM |
$0.083 |
$0.135 |
risen by
62.65%
|
|
| Income Asset Management Group Limited (IAM) ORDINARY FULLY PAID |
Financials |
$15 |
IAM Update
|
30 Jul 2025 10:07AM |
$0.029 |
$0.016 |
fallen by
44.83%
|
|
IAM - Price-sensitive ASX Announcement
Full Release
Key Points
- IAM experienced revenue growth and increased funds under advice and management for the half-year ended 31 December 2023.
- The company reported positive net operating cashflows and maintained a strong balance sheet.
- Strategic initiatives focused on digital transformation, operational efficiency, and improved client service and compliance.
- IAM invested in expanding distribution channels, technology, and strengthening industry partnerships.
- The company emphasized resilience in the face of market volatility and regulatory changes.
- Ongoing focus on client-centric outcomes and sustaining long-term shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Codeifai Limited (CDE) ORDINARY FULLY PAID |
Industrials |
$8 |
Proposed issue of securities - CDE
|
30 Jul 2025 10:04AM |
$0.026 |
$0.008 |
fallen by
69.23%
|
|
| ReNerve Limited (RNV) ORDINARY FULLY PAID |
Health Care |
$10 |
Quarterly Investor Webinar
|
30 Jul 2025 10:04AM |
$0.105 |
$0.075 |
fallen by
28.57%
|
|
| Codeifai Limited (CDE) ORDINARY FULLY PAID |
Industrials |
$8 |
Proposed issue of securities - CDE
|
30 Jul 2025 10:04AM |
$0.026 |
$0.008 |
fallen by
69.23%
|
|
| Codeifai Limited (CDE) ORDINARY FULLY PAID |
Industrials |
$8 |
Codeifai raises $2.35m via share Placement
|
30 Jul 2025 10:04AM |
$0.026 |
$0.008 |
fallen by
69.23%
|
|
CDE - Price-sensitive ASX Announcement
Full Release
Key Points
- Codeifai Limited has raised $2.35 million via a placement of new shares.
- The shares were placed at a price agreed upon with sophisticated and professional investors.
- Funds will be used to advance the Codeifai Development Environment (CDE), a core technology platform.
- Additional proceeds will support marketing initiatives and general working capital needs.
- The capital raise demonstrates investor confidence in Codeifai’s technology and business model.
- The placement is part of Codeifai’s strategy to scale operations and accelerate commercialization.
- The announcement date of the placement is May 29, 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| USCOM Ltd (UCM) ORDINARY FULLY PAID |
Health Care |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2025 10:03AM |
$0.011 |
$0.012 |
risen by
9.09%
|
|
UCM - Price-sensitive ASX Announcement
Full Release
Key Points
- USCOM Ltd progressed in global market penetration for its haemodynamic monitoring and pulmonary function testing devices.
- The company received cash inflows from product sales, government grants, and other sources.
- Ongoing investment was made in research, development, and regulatory approvals.
- Operational highlights include strengthened partnerships and expansion into new geographies.
- The company provided Appendix 4C cash flow details, showing net cash outflows for the quarter, mainly due to continued investment in R&D and product development.
- Management commentary outlines continued focus on operational improvements, regulatory strategies, and sustainable growth.
- Future priorities include further market expansion, regulatory submissions, and partnership development.
- No significant changes were reported in the structure or control of the company during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReNerve Limited (RNV) ORDINARY FULLY PAID |
Health Care |
$10 |
Q4 FY25 Activities Report and Appendix 4C
|
30 Jul 2025 10:03AM |
$0.105 |
$0.075 |
fallen by
28.57%
|
|
RNV - Price-sensitive ASX Announcement
Full Release
Key Points
- ReNerve Graft used in first-in-human surgery with successful outcomes.
- Progress toward regulatory and reimbursement milestones in Australia and internationally.
- Strengthened manufacturing operations and supply chain for commercialization readiness.
- Active engagement with surgeons, hospitals, and distributors to build a robust commercial pipeline.
- Ongoing efforts to secure funding and maintain financial sustainability.
- Receipt of R&D tax incentive contributing to cash inflows.
- Focus on generating clinical evidence to support regulatory filings and market adoption.
- Strategic planning for global expansion and partnership development.
- Appendix 4C provides detailed cashflow summary for the quarter.
- Outlook includes advancing commercialization and scaling operations for broader market reach.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
